We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTEM
5251
DELISTED
Molecular Templates, Inc.
MTEM
$406K ﹤0.01%
3,459
+955
+38% +$125K
QAT icon
5252
iShares MSCI Qatar ETF
QAT
$63.4M
$405K ﹤0.01%
21,400
GERN icon
5253
Geron
GERN
$828M
$404K ﹤0.01%
286,621
+52,409
+22% +$76.2K
PSR icon
5254
Invesco Active US Real Estate Fund
PSR
$59.4M
$403K ﹤0.01%
3,889
-4,781
-55% -$481K
RLMD icon
5255
CALL
Relmada Therapeutics
RLMD
$557M
$403K ﹤0.01%
12,600
CHMA
5256
DELISTED
Chiasma, Inc. Common Stock
CHMA
$403K ﹤0.01%
85,182
+32,453
+62% +$122K
RXRX icon
5257
Recursion Pharmaceuticals
RXRX
$1.59B
$402K ﹤0.01%
+11,013
New +$326K
ISMD icon
5258
Inspire Small/Mid Cap Impact ETF
ISMD
$332M
$401K ﹤0.01%
+10,919
New +$400K
VEON icon
5259
VEON
VEON
$3.62B
$401K ﹤0.01%
8,756
+5,199
+146% +$229K
PRT
5260
PermRock Royalty Trust Unit
PRT
$26.4M
$400K ﹤0.01%
56,190
-36,975
-40% -$233K
PPA icon
5261
Invesco Aerospace & Defense ETF
PPA
$8.24B
$399K ﹤0.01%
5,309
-5,640
-52% -$424K
XERS icon
5262
Xeris Biopharma Holdings
XERS
$1.39B
$399K ﹤0.01%
97,994
+11,902
+14% +$45.4K
VLTA
5263
DELISTED
Volta Inc.
VLTA
$398K ﹤0.01%
39,678
-112,203
-74% -$1.14M
CNCE
5264
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$398K ﹤0.01%
94,272
+25,687
+37% +$109K
EDTXU
5265
DELISTED
EdtechX Holdings Acquisition Corp. II Unit
EDTXU
$398K ﹤0.01%
39,001
COCHW icon
5266
Envoy Medical Warrant
COCHW
$425K
$397K ﹤0.01%
+427,152
New +$305K
NATR icon
5267
Nature's Sunshine
NATR
$354M
$397K ﹤0.01%
22,871
+9,889
+76% +$195K
CTXR icon
5268
Citius Pharmaceuticals
CTXR
$15.6M
$396K ﹤0.01%
+4,551
New +$274K
DFEB icon
5269
FT Vest US Equity Deep Buffer ETF February
DFEB
$461M
$394K ﹤0.01%
+11,500
New +$389K
BFLY icon
5270
CALL
Butterfly Network
BFLY
$1.89B
$392K ﹤0.01%
+27,100
New +$366K
AXDX
5271
DELISTED
Accelerate Diagnostics
AXDX
$391K ﹤0.01%
4,853
+1,601
+49% +$127K
MTL
5272
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$391K ﹤0.01%
192,427
+108,386
+129% +$222K
DFEN icon
5273
Direxion Daily Aerospace & Defense Bull 3X ETF
DFEN
$384M
$390K ﹤0.01%
+15,951
New +$374K
NWPX icon
5274
NWPX Infrastructure Inc
NWPX
$1.19B
$390K ﹤0.01%
13,811
+1,135
+9% +$36K
TELA icon
5275
TELA Bio
TELA
$32.7M
$389K ﹤0.01%
24,123
+3,605
+18% +$49.4K

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.